Rate this Article: Comparative Study of Additive IOP Lowering Effects and Safety Profile of Ripasudil 0.4% Combined with Timolol 0.5% and Ripasudil 0.4% Combined with Bimatoprost 0.03% In Primary Open Angle Glaucoma in Indian Eyes

Rating (1-10):

5

Comments (SR231206212100): Full Name: Email Address:

Back to Article